34
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A KEY ROLE FOR OREXIN IN PANIC ANXIETY

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Introductory paragraph

          Panic disorder is a severe anxiety disorder with recurrent, debilitating panic attacks. In subjects with panic disorder there is evidence of decreased central GABAergic activity as well as marked increases in autonomic and respiratory responses following intravenous infusions of 0.5M sodium lactate 13. In an animal model of panic disorder, chronic inhibition of GABA synthesis in the dorsomedial/perifornical hypothalamus of rats produces anxiety-like states and a similar vulnerability to sodium lactate-induced cardioexcitatory responses 49. The dorsomedial/perifornical hypothalamus is enriched in orexin (ORX, also known as hypocretin)-containing neurons 10 that play a critical role in arousal 10, 11, vigilance 10 and central autonomic mobilization 12, all of which are key components of panic. Here, we demonstrate that activation of the ORX neurons is necessary for developing a panic-prone state in the animal model, and either silencing the hypothalamic ORX gene ( Hcrt) product with RNA interference or systemic ORX1 antagonists blocks the panic responses. Moreover, we show that subjects with panic anxiety have elevated levels of ORX in the cerebrospinal fluid compared to subjects without panic anxiety. Taken together our results suggest that the ORX system may be involved in the pathophysiology of panic anxiety, and that ORX antagonists constitute a potential novel treatment strategy for panic disorder.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

          We describe a hypothalamus-specific mRNA that encodes preprohypocretin, the putative precursor of a pair of peptides that share substantial amino acid identities with the gut hormone secretin. The hypocretin (Hcrt) protein products are restricted to neuronal cell bodies of the dorsal and lateral hypothalamic areas. The fibers of these neurons are widespread throughout the posterior hypothalamus and project to multiple targets in other areas, including brainstem and thalamus. Hcrt immunoreactivity is associated with large granular vesicles at synapses. One of the Hcrt peptides was excitatory when applied to cultured, synaptically coupled hypothalamic neurons, but not hippocampal neurons. These observations suggest that the hypocretins function within the CNS as neurotransmitters.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness.

            Sleep and wakefulness are regulated to occur at appropriate times that are in accordance with our internal and external environments. Avoiding danger and finding food, which are life-essential activities that are regulated by emotion, reward and energy balance, require vigilance and therefore, by definition, wakefulness. The orexin (hypocretin) system regulates sleep and wakefulness through interactions with systems that regulate emotion, reward and energy homeostasis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Promotion of sleep by targeting the orexin system in rats, dogs and humans.

              Orexins are hypothalamic peptides that play an important role in maintaining wakefulness in mammals. Permanent deficit in orexinergic function is a pathophysiological hallmark of rodent, canine and human narcolepsy. Here we report that in rats, dogs and humans, somnolence is induced by pharmacological blockade of both orexin OX(1) and OX(2) receptors. When administered orally during the active period of the circadian cycle, a dual antagonist increased, in rats, electrophysiological indices of both non-REM and, particularly, REM sleep, in contrast to GABA(A) receptor modulators; in dogs, it caused somnolence and increased surrogate markers of REM sleep; and in humans, it caused subjective and objective electrophysiological signs of sleep. No signs of cataplexy were observed, in contrast to the rodent, dog or human narcolepsy syndromes. These results open new perspectives for investigating the role of endogenous orexins in sleep-wake regulation.
                Bookmark

                Author and article information

                Journal
                9502015
                8791
                Nat Med
                Nature medicine
                1078-8956
                1546-170X
                22 December 2009
                27 December 2009
                January 2010
                1 July 2010
                : 16
                : 1
                : 111-115
                Affiliations
                [1 ]Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202, U.S.A.
                [2 ]Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN 46202, U.S.A.
                [3 ]Department of Biochemistry, Indiana University School of Medicine, Indianapolis, IN 46202, U.S.A.
                [4 ]Section of Psychiatry, Department of Clinical Sciences, Lund University Hospital, 221 85 Lund, Sweden
                [5 ]Indiana Clinical and Translational Sciences Institute Indianapolis, IN 46202, USA
                Author notes
                [*]

                both authors made equal contribution to this report

                AUTHOR CONTRIBUTIONS AS, PLJ, and WT formulated the hypotheses and designed the studies. SDF and PLJ performed telemetrical probe surgeries. SDF and PLJ scored all behavior and SDF performed all stereotaxic surgeries. PLJ performed the immunohistochemistry. PEM and AD performed all RT-PCR assays with technical expertise from WT and SS. PLJ and WT analyzed all animal data. LT-B and LB were responsible for the human subject study, the ORX assays of the CSF samples and the analysis of the human data. PLJ, WT and AS interpreted the data and collectively wrote the main draft of the article. PJ, WT, SDF, AD, PK, LB, LT-B, AG and AS contributed to the writing of the manuscript and have approved of the final version.

                ADDRESS ALL CORRESPONDENCE TO: Anantha Shekhar Department of Psychiatry 791 Union Dr. Indianapolis, IN 46202 T: 317-278-6969 F: 317-278-4821 ashekhar@ 123456iupui.edu
                Article
                nihpa165718
                10.1038/nm.2075
                2832844
                20037593
                c63ab6cc-a7da-4fb9-bdce-0e4800b75cf9

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Center for Research Resources : NCRR
                Funded by: National Institute of Mental Health : NIMH
                Award ID: UL1 RR025761-015988 ||RR
                Funded by: National Center for Research Resources : NCRR
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH065702-06 ||MH
                Funded by: National Center for Research Resources : NCRR
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH052619-11 ||MH
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article